Literature DB >> 25243318

Undifferentiated uterine carcinoma: analysis of eighteen cases.

I Üreyen1, H Ilgin, T Turan, T Taşçi, A Karalök, N Boran, A Özfuttu, G Tulunay.   

Abstract

Analysis of the surgicopathological characteristics and clinical follow-up of patients with undifferentiated uterine carcinoma (UUC) was conducted. A total of 18 cases operated between January 1993 and December 2013 were included. Among 1,690 patients with endometrial cancer, 18 patients (1.1%) had UUC. Lymph node involvement was detected in 70.6%; depth of myometrial invasion was ≥ 0.5 in 55.6%; lymphovascular space invasion was detected in 99.3%; cervical stromal invasion was positive in 27.8%; omental and adnexal involvement were detected in 11.8% and 38.9%, respectively. The median follow-up time of the 12 patients evaluated in the survival analysis was 66 months. In the follow-up period, recurrence or progression during adjuvant therapy were observed in four patients (33.3%) and two patients (16.6%) died of the disease. UUC manifests as an aggressive tumour. In conclusion, a high rate of survival could be achieved with complete staging surgery, including an extensive lymphadenectomy with the contribution of adjuvant therapy.

Entities:  

Keywords:  Endometrial cancer; surgicopathological factors; survival; undifferentiated tumour

Mesh:

Year:  2014        PMID: 25243318     DOI: 10.3109/01443615.2014.958441

Source DB:  PubMed          Journal:  J Obstet Gynaecol        ISSN: 0144-3615            Impact factor:   1.246


  3 in total

Review 1.  [Un- and dedifferentiated endometrial carcinoma : A rare entity with a wide range of differential diagnosis].

Authors:  A K Höhn; C E Brambs; S Opitz; R Erber; A Hartmann; L-C Horn
Journal:  Pathologe       Date:  2019-11       Impact factor: 1.011

2.  Rapid progression of disease in two cases of undifferentiated endometrial carcinoma.

Authors:  Krista S Pfaendler; Leslie M Randall
Journal:  Gynecol Oncol Rep       Date:  2019-01-18

3.  Treatment and outcomes in undifferentiated and dedifferentiated endometrial carcinoma.

Authors:  Sarah Nicole Hamilton; Anna V Tinker; Janice Kwon; Peter Lim; Iwa Kong; Sona Sihra; Martin Koebel; Cheng Han Lee
Journal:  J Gynecol Oncol       Date:  2022-01-24       Impact factor: 4.756

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.